Colinz Labs
Company Overview - January 14, 2025
Colinz Labs is a notable player in the Pharmaceuticals - Indian - Formulations industry, listed on the BSE (Code: 531210). As of the January 14, 2025, the company holds a market capitalization of INR 26.40 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 57.76, Colinz Labs has demonstrated a 39.83% return over the last year. Recent performance indicates fluctuations, with a 5.22% change in the past week and a 2.68% change over the last month. The company's all-time high stands at INR 84.40, while its lowest-ever price was INR 2.90.
In terms of sales, Colinz Labs reported a revenue of INR 6.95 crores, solidifying its position in the market. The average trading volume over the past month has been 1513 shares, with a more recent weekly average of 1066.
With the stock trading below its 50-day moving average of INR 58.25, the company's technical indicators like MACD (-0.88) signal negative trends.
Company Data
| Name | Colinz Labs |
|---|---|
| BSE Code | 531210 |
| NSE Code | |
| Industry | Pharmaceuticals - Indian - Formulations |
| Current Price | 57.76 |
| Market Capitalization | 26.40 |
| Sales | 6.95 |
| Return over 3months | 5.72 |
| Return over 6months | 46.85 |
| Volume 1month average | 1513 |
| Volume 1week average | 1066 |
| Volume | 544 |
| High price | 84.40 |
| Low price | 36.00 |
| High price all time | 84.40 |
| Low price all time | 2.90 |
| Return over 1day | -0.22 |
| Return over 1week | 5.22 |
| Return over 1month | 2.68 |
| Return over 1year | 39.83 |
| Return over 3years | 42.04 |
| Return over 5years | 43.06 |
| Volume 1year average | 2760 |
| DMA 50 | 58.25 |
| DMA 200 | 53.07 |
| DMA 50 previous day | 58.26 |
| DMA 200 previous day | 53.02 |
| MACD | -0.88 |
| MACD Signal | -0.26 |